Weinshilboum R M, Otterness D M, Aksoy I A, Wood T C, Her C, Raftogianis R B
Department of Pharmacology, Mayo Medical School/Mayo Clinic/Mayo Foundation, Rochester, Minnesota 55905, USA.
FASEB J. 1997 Jan;11(1):3-14.
Sulfotransferase (ST) enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. These reactions result in enhanced renal excretion of the sulfate-conjugated reaction products, but they can also lead to the formation of "bioactivated" metabolites. ST enzymes are members of an emerging gene superfamily that presently includes phenol ST (PST), hydroxysteroid ST (HSST), and, in plants, flavonol ST (FST) "families," members of which share at least 45% amino acid sequence identity. These families can be further subdivided into "subfamilies" that are at least 60% identical in amino acid sequence. For example, the PST family includes both PST and estrogen ST (EST) subfamilies. Amino acid sequence motifs exist within ST enzymes that are conserved throughout phylogeny. These signature sequences may be involved in the binding of 3'-phosphoadenosine-5 '-phosphosulfate, the cosubstrate for the sulfonation reaction. There are presently five known human cytosolic ST enzymes: an EST, an HSST, and three PSTs. cDNAs and genes for all of these enzymes have been cloned, and chromosomal localizations have been reported for all five genes. Genes for these human enzymes, as well as those of other mammalian cytosolic ST enzymes that have been cloned, show a high degree of structural homology, with conservation of the locations of most intron/exon splice junctions. Human ST enzyme expression varies among individuals. Functionally significant genetic polymorphisms for ST enzymes in humans have been reported, and other molecular genetic mechanisms that might be involved in the regulation of the expression of these enzymes are being explored. Knowledge of the molecular biology of cytosolic ST enzymes, when placed within a context provided by decades of biochemical research, promises to significantly enhance our understanding of the regulation of the sulfate conjugation of hormones, neurotransmitters, and drugs.
磺基转移酶(ST)催化多种激素、神经递质、药物及外源性化合物的硫酸化结合反应。这些反应使得硫酸化结合反应产物的肾脏排泄增加,但也可能导致“生物活化”代谢物的形成。ST酶是一个新兴基因超家族的成员,目前包括酚类ST(PST)、羟基类固醇ST(HSST),在植物中还包括黄酮醇ST(FST)“家族”,其家族成员之间至少有45%的氨基酸序列同一性。这些家族可进一步细分为氨基酸序列至少60%相同的“亚家族”。例如,PST家族包括PST和雌激素ST(EST)亚家族。ST酶中存在贯穿系统发育过程保守的氨基酸序列基序。这些特征序列可能参与了磺化反应的共底物3'-磷酸腺苷-5'-磷酸硫酸的结合。目前已知有五种人类胞质ST酶:一种EST、一种HSST和三种PST。所有这些酶的cDNA和基因均已克隆,并且已报道了所有五个基因的染色体定位。这些人类酶的基因以及已克隆的其他哺乳动物胞质ST酶的基因显示出高度的结构同源性,大多数内含子/外显子剪接位点的位置保守。人类ST酶的表达因人而异。已报道了人类ST酶具有功能意义的基因多态性,并且正在探索可能参与这些酶表达调控的其他分子遗传机制。将胞质ST酶的分子生物学知识置于数十年生化研究提供的背景中,有望显著增进我们对激素、神经递质和药物硫酸化结合反应调控的理解。